To determine if multiparametric (mp) magnetic resonance imaging (MRI) can identify significant apical disease, thereby informing decisions regarding preservation of the membranous urethra.
Introduction
The goal of radical prostatectomy (RP) is to achieve oncological control with minimal intra-operative and perioperative complications and preservation of quality of life. Despite stage migration, attributable to PSA screening and description of the Walsh anatomical RP, up to 30% of men will develop biochemical recurrence [1] ; achievement of oncological control therefore remains a limitation of RP [2] . Because approximately half of men undergoing salvage radiation therapy experience a durable oncological response, a significant proportion of disease recurrences after RP are attributable to failure to achieve local disease control [3] . The development of urinary incontinence also remains a significant limitation of RP [4] .
Multiple studies have shown a direct relationship between membranous urethra length (MUL) and improved post-prostatectomy continence [5, 6] ; therefore, a surgical strategy maximizing MUL may be prudent, providing apical surgical margins are not compromised. Oncological control is an important consideration because many studies have shown that the apex is the most common site of positive surgical margins after RP [7, 8] .
Systematic biopsy (SB) and MRI have the potential to identify aggressive apical prostate cancer (APCa) and inform decisions regarding maximizing MUL. The aim of the present study was to compare the ability of SB and multiparametic (mp) MRI to detect aggressive prostate cancer, defined as any prostate cancer grade group >1 in the distal 5 mm of the prostatic apex (PA) of RP specimens.
Materials and Methods
The records of men participating in an institutional review board-approved prospective outcomes study who underwent open retropubic RP by a single surgeon (H.L.) at New York University Langone Medical Center between January 2012 and June 2016 were queried. At our institution, most men undergoing RP have undergone 12-core TRUS-guided SB, preoperative staging mpMRI, and postoperative sectioning and mapping of the surgical specimen.
The RP surgical specimens were sectioned 3 mm cranially to caudally, with a separate proximal base and distal apical margins of 1-2 mm. The PA was represented by the two distal most apical 3-mm sections. The prostate sections were stained with haematoxylin and eosin and traced onto glass slides. The location, size and Gleason score of all cancers found in these individual segments were mapped to scale on visual representations of the sections [9] .
A total of 100 men underwent SB, preoperative prostate 3-Tesla MRI at our institution, and mapping of the surgical specimen. MRI examinations were consistently performed at least 6 weeks after prostate biopsy in order to minimize artifact from post-biopsy haemorrhage and included T2-weighted, diffusion-weighted, and dynamic contrastenhanced imaging using a previously reported acquisition methodology [10] . The MRI sequences were retrospectively reviewed by a single attending radiologist (T.T.), blinded to the biopsy and histological findings regarding tumour grade and location within the prostate. The radiologist reviewed images to detect the presence of findings suspicious for tumour in the PA, assigning a suspicion score for all MRI lesions observed in the distal third of the prostate using a Likert scale of 1-5. Because the majority of cases did not undergo MRI fusion coregistration biopsy at our institution, we were unable to investigate the utility of targeted biopsy to increase prediction of apical margin status. A validated contemporary prostate cancer grading system, ranging between 1 and 5, was used to assess aggressiveness of the disease [11] . A prostate cancer grade >1 was considered aggressive disease.
The MRI lesions were graded using a previously reported Likert scale to assess the suspicion for prostate cancer [12, 13] . The presence of an MRI lesion with a Likert score >2 extending into the distal third of the prostate was compared with the presence of APCa in the PA. Additionally, the presence of any tumour in the apical SB specimens was also correlated with the presence of APCa in the PA. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of Likert score >2 and apical SB were compared with regard to predicting APCa in the PA.
In cases with Likert score >2 lesions in the distal third of the prostate, the radiologist separately assigned an additional score of between 1 and 5, reflecting the relationship of the MRI lesion to the prostatic capsule. A prostatic capsule involvement score (PCIS) of 1 represented <10 mm abutment of the prostatic capsule; a PCIS of 2 represented >10 mm abutment of the prostatic capsule; a PCIS of 3 represented irregular or speculated involvement of the prostatic capsule; a PCIS of 4 represented definite interruption of the capsule; and a PCIS of 5 represented obliteration of peri-prostatic fat. These PCISs were correlated with the presence of extraprostatic extension (EPE) in the distal third of the prostate. The sensitivity, specificity, PPV and NPV of the PCIS for predicting EPE was calculated.
A receiver-operator characteristic (ROC) curve was generated for Likert score using IBM SPSS 23 (IBM Corp., Armonk, NY, USA). A binary logistic regression was conducted including apical Likert score (categorical value with ≥3 as a threshold), age, preoperative serum PSA level, prostate size and presence of any cancer on apical SB as independent variables for predicting APCa in the PA.
Results
A total of 100 cases were included in the study. Baseline characteristics and pathological assessment of the surgical specimens are shown for the entire cohort and for those with and without APCa in the PA in Table 1 . Overall, 43 (43%) of the cases exhibited APCa in the PA. The group with cancer in the PA had a significantly higher baseline PSA, pathological stage, and rate of positive surgical margins and positive apical surgical margins. Of the 43 patients positive and 57 patients negative for APCa, 18 (41.9%) and 17 (29.8%), respectively, had undergone MRI-fusion-targeted biopsy (P = 0.21). MRIfusion-targeted biopsy was not associated with a significantly greater probability of detecting APCa.
Overall, only six (6%) of the cohort exhibited positive apical surgical margins. Of the 43 APCa-positive cases, only six (14.0%) and nine (20.9%) exhibited positive apical surgical margins and any positive surgical margins, respectively. Of the 57 APCa-negative cases, none and two (3.5%) exhibited positive apical surgical margins and any positive surgical margins, respectively.
The sensitivity, specificity, PPV and NPV data for various Likert scores to predict APCa is shown in Table 2 . A Likert score >2 in the distal third of the prostate achieved the optimum operator mechanics for predicting APCa at the PA. Using this threshold, the NPV and sensitivity of MRI for APCa at the PA were 76.5% and 81.4%, respectively. MRI missed eight cases of APCa (18.6%) at the PA. The two prostate cancer grade 3 cancers missed by MRI were ≤5 mm.
Binary logistic regression analysis was used to determine independent predictors of APCa in the PA (Table 3) . A Likert score >2 was the most significant predictor of APCa at the PA (odds ratio 4.17, 95% CI 1.54-11.29). Baseline serum PSA was also a significant predictor of APCa at the PA (odds ratio 1.15, 95% CI 1.02-1.31). Age, prostate size and the presence of any cancer on apical SB were not significant independent predictors of APCa in the PA. While pathological stage was significantly 240 © 2017 The Authors BJU International © 2017 BJU International different between the APCa-positive and APCa-negative PA cohorts in univariate analysis, only preoperative characteristics were included in the multivariate analysis because the objective of the study was to predict APCa preoperatively.
Of the eight cases exhibiting EPE at the distal third of the prostate, seven were non-focal EPE according to the Epstein criteria [14, 15] . Of the 66 MRI apical lesions with a Likert score >2, 22 (33%) had a PCIS >2. Using an MRI PCIS >2 as a threshold, MRI had a sensitivity of 62.5%, a specificity of 80.2%, a PPV of 21.7% and a NPV of 96.1% for identifying EPE at the distal third of the prostate (Table 4 ).
An ROC curve was generated for apical Likert score as a test for APCa at the PA (Fig. 1) . Apical Likert score exhibited an area under the curve of 0.721, with a 95% CI of 0.619-0.822. Based on ROC analysis, the optimum threshold for Likert score to predict APCa was ≥3.
Discussion
Urinary incontinence is associated with an adverse impact on quality of life after RP. Over the past decade, several surgical modifications have been proposed to improve urinary continence after RP without consensus about benefit. Rocco et al. [16] reported that approximating the posterior rhabdosphincter improved return to continence, while Menon et al. [17] subsequently failed to show any benefit of the 'Rocco' stitch.
Some authors have advocated preservation of the puboprostatic ligament in order to improve return to continence [18] . A subsequent parallel randomized controlled trial failed to confirm the benefit of pubo-prostatic ligament preservations [17] .
There is a consensus that preservation of urinary continence after RP can be attributed to a functional distal rhabdospincter [19, 20] . The MUL can be measured both before and after RP. Before RP, the MUL represents the distance from the PA to the proximal penile bulb. After RP, the MUL represents the distance from the bladder neck to the proximal penile bulb. The pre-and postoperative MUL has been shown to predict preservation of urinary continence after RP; therefore, maximizing MUL is a reasonable strategy for decreasing post-prostatectomy urinary continence. A potential limitation of maximal preservation of the MUL during RP is the compromising of oncological control. The distal apex is the most common site of positive surgical margins [7, 8, 21] , regardless of whether the operation is performed with an open or robot-assisted approach. A reliable road map showing the presence or absence of APCa at the PA may inform surgeons when to implement this surgical modification.
Both SB and MRI have the potential to identify APCa at the PA and inform decisions regarding maximizing MUL. Our group has previously shown that SB does not reliably predict an apical positive surgical margin [7, 22] . A subsequent study by Iremashvili et al. [23] also showed the poor NPV of SB for determining the presence of cancer in the PA. Wright and Ellis [24] demonstrated increased sensitivity of SB for predicting positive surgical margins at the PA by increasing tissue sampling of the apex.
In the present study, SB was not a significant predictor of APCa at the PA using a multivariate model. In addition, the NPV of SB for APCa in the PA was only 64.5%. The present study confirms that the surgeon cannot reliably plan whether to maximize MUL based on the SB alone.
Magnetic resonance imaging has emerged as an important tool for screening and detection of prostate cancer [25, 26] , and its utility for preoperative planning has shown promise [27, 28] . There is increasing evidence that the site of the index tumour is reliably identified by mpMRI [10, 29] . Yao et al. [30] showed that apical positivity on MRI was a significant predictor of a positive surgical margin.
Owing to the ability of mpMRI to localize APCa, the present study was designed to evaluate its ability to identify APCa at the PA. We observed a sensitivity and NPV of MRI for predicting APCa at the PA of 81.4% and 76.5%, respectively. We also observed an NPV of MRI for predicting EPE in the apical third of prostate of 96.1%. This high NPV of MRI for EPE rules out distal apical peri-prostatic involvement with a high level of confidence.
Using a multivariate model, MRI was a significant predictor of APCa at the PA. The results of the present study show that MRI is a useful but imperfect tool for identifying APCa at the PA and can guide the surgeon when preserving MUL is appropriate.
Nix et al. [31] reported that MRI-fusion-targeted biopsy and SB detect 45.5% vs 24.4% of distal apical tumours, respectively. They did not stratify for aggressive disease. MRIfusion-targeted biopsy is probably the optimal way to detect APCa at the PA. Today, MRI is widely used for preoperative staging before RP. As a result of technical and reimbursement issues, MRI-fusion-targeted biopsy is not the standard of care, especially in men undergoing initial prostate biopsy. The present study shows that MRI alone can achieve a sensitivity of >80% for APCa at the PA. For those surgeons contemplating maximizing MUL in order to improve continence, MRI may be useful to inform decisions for patient selection. A Likert score >2 in the distal third of the prostate should raise suspicion for APCa at the PA. A Likert score <3 in the distal third of the prostate provides reassurance that ECE will not be identified at the PA.
There are some limitations to this study that should be noted. First, our institution has a long experience with performing and interpreting prostate MRI and it is possible that our outcomes are not generalizable to practice settings in which radiologists are less experienced. Further, the study design was retrospective and there may be some unrecognized bias between the groups. There is no consensus regarding the definition of significant prostate cancer. We assumed that prostate cancer grade groups >1 represent significant prostate because in modern RP series, only 11.4% and 20.1% of cases have biopsy or pathological prostate cancer grade groups >2, respectively [32] . Finally, our cohort was small and In light of these findings, we believe apical MRI is a useful test for detection of APCa and therefore represents a promising tool for surgical planning as it relates to the extent of preservation of MUL.
